The global vaccines market is projected to reach US$58.4 billion by 2024 from US$41.7 billion in 2019, at a CAGR of 7.0% during the forecast period."

Finally, market participants who do not want to commit full capital to any single name could consider buying a thematic exchange-traded fund (ETF). Examples include:

• ETFMG Treatments, Testing and Advancements ETF (NYSE:GERM)

• SPDR® S&P Biotech ETF (NYSE:XBI)

• VanEck Vectors Biotech ETF (NASDAQ:BBH)

• Virtus LifeSci Biotech Clinical Trials ETF (NYSE:BBC)

1 Like

This topic was automatically closed 416 days after the last reply. New replies are no longer allowed.